JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB236945

Anti-HEXO antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal HEXO antibody. Suitable for IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human ERI1 aa 1-100.

View Alternative Names

3'EXO, THEX1, 3`EXO, ERI1, 3'-5' exoribonuclease 1, 3'-5' exonuclease ERI1, Eri-1 homolog, Histone mRNA 3'-end-specific exoribonuclease, Histone mRNA 3'-exonuclease 1, Protein 3'hExo, HEXO

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEXO antibody (AB236945)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEXO antibody (AB236945)

Paraffin-embedded human testis tissue stained for HEXO using ab236945 at 1/400 dilution in immunohistochemical analysis.

After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

Immunocytochemistry/ Immunofluorescence - Anti-HEXO antibody (AB236945)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-HEXO antibody (AB236945)

4% formaldehyde-fixed, 0.2% Triton X-100 permeabilized HepG2 (human liver hepatocellular carcinoma cell line) cells stained for HEXO (green) using ab236945 at 1/133 dilution in ICC/IF, followed by Alexa Fluor 488® conjugated Goat Anti-Rabbit IgG (H+L). Counter-stained with DAPI.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEXO antibody (AB236945)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HEXO antibody (AB236945)

Paraffin-embedded human small intestine tissue stained for HEXO using ab236945 at 1/400 dilution in immunohistochemical analysis.

After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human ERI1 aa 1-100. The exact immunogen used to generate this antibody is proprietary information.

Q8IV48

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200 - 1/500", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/200", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purity >95%.
Storage buffer
pH: 7.4 Preservative: 0.03% Proclin 300 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HEXO also known as Hexokinase is an enzyme with several isoforms expressed in different tissues. It plays an important role in the initial step of glycolysis by phosphorylating glucose to form glucose-6-phosphate. The mass of HEXO varies depending on the isoform; for example Hexokinase I typically has a mass around 102-104 kDa. HEXO is expressed in the cytoplasm of cells but specific isoforms like Hexokinase II are found on the outer membrane of mitochondria. This mitochondrial association is important for its regulatory function and activity in tissues such as muscle and brain.
Biological function summary

HEXO is significant in energy metabolism. It converts glucose into glucose-6-phosphate setting off the glycolytic pathway and linking to other pathways such as the pentose phosphate pathway. HEXO often functions as part of a larger enzyme complex within the cell collaborating with other glycolytic enzymes to efficiently metabolize glucose. Its activity influences cellular energy homeostasis and biosynthetic processes impacting cellular growth and division.

Pathways

HEXO is a central enzyme in carbohydrate metabolism and plays an important role in the glycolysis and pentose phosphate pathways. In glycolysis HEXO catalyzes the first committed step which is important for the production of ATP and metabolic intermediates. In the pentose phosphate pathway it provides glucose-6-phosphate as a substrate which is essential for the generation of NADPH and ribose-5-phosphate. Proteins like Glucose-6-phosphate dehydrogenase (G6PD) work with HEXO in the pentose phosphate pathway showcasing a collaborative role in oxidative stress response and anaplerotic reactions.

Impaired hexokinase function can be linked to conditions such as diabetes and cancer. These disorders exhibit alterations in glucose metabolism where reduced or aberrant activity of HEXO affects cellular energy balance and proliferation. For instance decreased HEXO activity relates to insulin resistance in diabetes impacting glucose uptake and metabolism. In cancer the unique association of certain hexokinase isoforms with mitochondria influences apoptosis resistance often involving proteins like VDAC (Voltage-dependent anion channel) which HEXO interacts with contributing to altered metabolic phenotypes in cancer cells.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

RNA exonuclease that binds to the 3'-end of histone mRNAs and degrades them, suggesting that it plays an essential role in histone mRNA decay after replication (PubMed : 14536070, PubMed : 16912046, PubMed : 17135487, PubMed : 37352860). A 2' and 3'-hydroxyl groups at the last nucleotide of the histone 3'-end is required for efficient 3'-end histone mRNA exonuclease activity and degradation of RNA substrates (PubMed : 14536070, PubMed : 16912046, PubMed : 17135487). Also able to degrade the 3'-overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi) (PubMed : 14961122). Required for binding the 5'-ACCCA-3' sequence present in stem-loop structure (PubMed : 14536070, PubMed : 16912046). Able to bind other mRNAs (PubMed : 14536070, PubMed : 16912046). Required for 5.8S rRNA 3'-end processing (PubMed : 37352860). Also binds to 5.8s ribosomal RNA (By similarity). Binds with high affinity to the stem-loop structure of replication-dependent histone pre-mRNAs (PubMed : 14536070, PubMed : 16912046, PubMed : 17135487). In vitro, does not have sequence specificity (PubMed : 17135487). In vitro, has weak DNA exonuclease activity (PubMed : 17135487). In vitro, shows biphasic kinetics such that there is rapid hydrolysis of the last three unpaired RNA nucleotides in the 39 flanking sequence followed by a much slower cleavage through the stem that occurs over a longer incubation period in the order of hours (PubMed : 17135487). ERI1-mediated RNA metabolism plays a key role in chondrogenesis (PubMed : 37352860).
See full target information ERI1

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

iScience 28:112748 PubMed40585507

2025

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

Applications

Unspecified application

Species

Unspecified reactive species

Petros Kechagioglou,Hajime Yurugi,Camille Dupont,Alexey Chernobrovkin,Rossana Romero,Gregory Harms,Marie Oster,Sandra Ciesek,Rebecca Tweedell,Thirumala-Devi Kanneganti,Stefanie Zimmer,Stephen Cosenza,Steven M Fruchtman,Krishnaraj Rajalingam
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com